☰

Matthew S. Beatty, Ph.D. - Publications

Affiliations: 
2013 Pathology University of Alabama, Birmingham, Birmingham, AL, United States 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Bazargan S, Bunch B, Ojwang' AME, Blauvelt J, Landin A, Ali J, Abrahams D, Cox C, Hall AM, Beatty MS, Poch M, Rejniak KA, Pilon-Thomas S. Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer. Frontiers in Immunology. 14: 1275375. PMID 37901214 DOI: 10.3389/fimmu.2023.1275375  0.367
2020 Bunch BL, Morse J, Asby S, Blauvelt J, Aydin AM, Innamarato P, Hajiran A, Beatty M, Poch M, Pilon-Thomas S. Systemic and intravesical adoptive cell therapy of tumor-reactive T cells can decrease bladder tumor growth in vivo. Journal For Immunotherapy of Cancer. 8. PMID 33303579 DOI: 10.1136/jitc-2020-001673  0.343
2020 Wu H, Estrella V, Beatty M, Abrahams D, El-Kenawi A, Russell S, Ibrahim-Hashim A, Longo DL, Reshetnyak YK, Moshnikova A, Andreev OA, Luddy K, Damaghi M, Kodumudi K, Pillai SR, et al. T-cells produce acidic niches in lymph nodes to suppress their own effector functions. Nature Communications. 11: 4113. PMID 32807791 DOI: 10.1038/S41467-020-17756-7  0.33
2020 Innamarato P, Kodumudi K, Asby S, Schachner B, Hall M, Mackay A, Wiener D, Beatty M, Nagle L, Creelan BC, Sarnaik AA, Pilon-Thomas S. Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell Therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 32615068 DOI: 10.1016/J.Ymthe.2020.06.025  0.418
2020 Hesterberg RS, Beatty MS, Han Y, Fernandez MR, Akuffo AA, Goodheart WE, Yang C, Chang S, Colin C, Alontaga AY, McDaniel J, Mailloux AW, Billington JMR, Yue L, Russell S, et al. Cereblon Harnesses Myc-Dependent Bioenergetics and Activity of CD8+ T lymphocytes. Blood. PMID 32403132 DOI: 10.1182/Blood.2019003257  0.366
2019 Yue L, Sharma V, Horvat NP, Akuffo AA, Beatty MS, Murdun C, Colin C, Billington J, Goodheart WE, Sahakian E, Zhang L, Powers JJ, Amin NE, Lambert-Showers QT, Darville LN, et al. HDAC11 Deficiency or Inhibition Disrupts Oncogene-Induced Stress Hematopoiesis in Myeloproliferative Neoplasms. Blood. PMID 31750881 DOI: 10.1182/Blood.2019895326  0.331
2018 Poch M, Hall M, Joerger A, Kodumudi K, Beatty M, Innamarato PP, Bunch BL, Fishman MN, Zhang J, Sexton WJ, Pow-Sang JM, Gilbert SM, Spiess PE, Dhillon J, Kelley L, et al. Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer. Oncoimmunology. 7: e1476816. PMID 30228944 DOI: 10.1080/2162402X.2018.1476816  0.355
2018 Akuffo AA, Alontaga AY, Metcalf R, Beatty MS, Becker A, McDaniel JM, Hesterberg RS, Goodheart WE, Gunawan S, Ayaz M, Yang Y, Karim MR, Orobello ME, Daniel K, Guida W, et al. Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon. The Journal of Biological Chemistry. PMID 29449372 DOI: 10.1074/Jbc.M117.816868  0.33
2015 Beatty MS, Timares L, Curiel DT. Augmented adenovirus transduction of murine T lymphocytes utilizing a bi-specific protein targeting murine interleukin 2 receptor. Cancer Gene Therapy. 22: 222. PMID 25904493 DOI: 10.1038/cgt.2015.13  0.42
2015 Beatty MS, Hesterberg RS, Han Y, Padron E, Mailloux AW, Yoder S, Rajadhyaksha AM, List AF, Epling-Burnette PK. Cereblon Deficiency Leads to Alteration in c-Myc Regulated Genes, Increased Glucose Uptake and Resistance to JQ1 Bromodomain Inhibition Blood. 126: 286-286. DOI: 10.1182/Blood.V126.23.286.286  0.395
2013 Beatty MS, Timares L, Curiel DT. Augmented adenovirus transduction of murine T lymphocytes utilizing a bi-specific protein targeting murine interleukin 2 receptor. Cancer Gene Therapy. 20: 445-52. PMID 23928733 DOI: 10.1038/Cgt.2013.39  0.474
2012 Beatty MS, Curiel DT. Chapter two--Adenovirus strategies for tissue-specific targeting. Advances in Cancer Research. 115: 39-67. PMID 23021241 DOI: 10.1016/B978-0-12-398342-8.00002-1  0.441
2008 San Martín C, Glasgow JN, Borovjagin A, Beatty MS, Kashentseva EA, Curiel DT, Marabini R, Dmitriev IP. Localization of the N-terminus of minor coat protein IIIa in the adenovirus capsid. Journal of Molecular Biology. 383: 923-34. PMID 18786542 DOI: 10.1016/J.Jmb.2008.08.054  0.372
Show low-probability matches.